Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.
3.
4.
5.

IgG4 specific to Toxoplasma gondii excretory/secretory antigens in serum and/or cerebrospinal fluid support the cerebral toxoplasmosis diagnosis in HIV-infected patients.

Meira CS, Vidal JE, Costa-Silva TA, Motoie G, Gava R, Hiramoto RM, Pereira-Chioccola VL.

J Immunol Methods. 2013 Sep 30;395(1-2):21-8. doi: 10.1016/j.jim.2013.06.005. Epub 2013 Jun 26.

PMID:
23811152
6.
8.

Involvement of Host Defense Mechanisms against Toxoplasma gondii Infection in Anhedonic and Despair-Like Behaviors in Mice.

Mahmoud ME, Fereig R, Nishikawa Y.

Infect Immun. 2017 Mar 23;85(4). pii: e00007-17. doi: 10.1128/IAI.00007-17. Print 2017 Apr.

9.

Kinetics of systemic cytokine and brain chemokine gene expression in murine toxoplasma infection.

Aviles H, Stiles J, O'Donnell P, Orshal J, Leid J, Sonnenfeld G, Monroy F.

J Parasitol. 2008 Dec;94(6):1282-8. doi: 10.1645/GE-1309.1.

PMID:
19127964
10.

Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes.

Halonen SK, Chiu F, Weiss LM.

Infect Immun. 1998 Oct;66(10):4989-93.

11.

Immunopathogenesis of cerebral toxoplasmosis.

Suzuki Y.

J Infect Dis. 2002 Dec 1;186 Suppl 2:S234-40. Review.

PMID:
12424703
12.

Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain.

Suzuki Y, Sa Q, Gehman M, Ochiai E.

Expert Rev Mol Med. 2011 Oct 4;13:e31. doi: 10.1017/S1462399411002018. Review.

13.

HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines.

Gazzinelli RT, Bala S, Stevens R, Baseler M, Wahl L, Kovacs J, Sher A.

J Immunol. 1995 Aug 1;155(3):1565-74.

PMID:
7636218
14.

Behavior of Neutrophil Granulocytes during Toxoplasma gondii Infection in the Central Nervous System.

Biswas A, French T, Düsedau HP, Mueller N, Riek-Burchardt M, Dudeck A, Bank U, Schüler T, Dunay IR.

Front Cell Infect Microbiol. 2017 Jun 21;7:259. doi: 10.3389/fcimb.2017.00259. eCollection 2017.

15.

MyD88 is crucial for the development of a protective CNS immune response to Toxoplasma gondii infection.

Torres M, Guiton R, Lacroix-Lamandé S, Ryffel B, Leman S, Dimier-Poisson I.

J Neuroinflammation. 2013 Feb 1;10:19. doi: 10.1186/1742-2094-10-19.

16.

Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.

Schlüter D, Kwok LY, Lütjen S, Soltek S, Hoffmann S, Körner H, Deckert M.

J Immunol. 2003 Jun 15;170(12):6172-82.

17.

Evolution of cytokine profile during the treatment of cerebral toxoplasmosis in HIV-infected patients.

Meira Cda S, Pereira-Chioccola VL, Vidal JE, Motoie G, Costa-Silva TA, Gava R; Toxoplasma Group.

J Immunol Methods. 2015 Nov;426:14-8. doi: 10.1016/j.jim.2015.07.005. Epub 2015 Jul 12.

PMID:
26177476
19.

Supplemental Content

Support Center